文献速递多重用药认知障碍与谵妄老年综合评估

认知担忧老年患者中抗胆碱能与镇静药物使用情况

Anticholinergic and sedative medication use in older patients with cognitive concerns.
PubMed 文献 · J Am Geriatr Soc · 2024-04-29

本研究对392例接受门诊神经心理评估的老年患者进行横断面病历回顾,发现多重用药、镇静药和抗胆碱能药使用普遍;镇静药使用与注意力/处理速度及执行功能负相关,抗胆碱能负荷与注意力/处理速度负相关,但未发现与记忆的关联。

要点

  • 多重用药占80%,70%使用≥1种镇静药,63%使用≥1种抗胆碱能药。
  • 镇静药使用与注意力/处理速度及执行功能负相关。
  • 抗胆碱能负荷与注意力/处理速度负相关,但未发现与记忆关联。

核心结论

  • 抗胆碱能药、镇静药和多重用药在认知担忧老年患者中普遍存在,镇静药与注意力/处理速度的负关联尤为突出。

研究设计与样本

  • 横断面病历回顾,纳入392例接受门诊神经心理评估的患者,平均年龄72±7.7岁(范围54-91岁)。

主要发现

  • 多重用药(≥5种每日药物)占80%(n=314)。
  • 70%(n=275)使用≥1种镇静药(范围0-9种)。
  • 63%(n=248)使用≥1种抗胆碱能药(范围0-7种),但74%患者ACB评分≤2。
  • 镇静药使用与注意力/处理速度(r=-0.134,p=0.008)及执行功能(r=-0.105,p=0.04)负相关。
  • ACB评分与注意力/处理速度负相关(r=-0.106,p=0.037),未发现与记忆的显著关联。

关键数值与推荐

  • 抗胆碱能负荷采用抗胆碱能认知负担量表(ACB)评估,≥1种ACB药物定义为使用抗胆碱能药。
  • 多重用药定义为每日用药≥5种。
  • 多变量线性回归显示镇静药数量与注意力/处理速度独立负相关(β=-0.426,p=0.049),模型R²=0.127,p<0.001。

临床怎么用

  • 对认知担忧的老年患者应常规审查镇静药和抗胆碱能药使用,尤其关注注意力/处理速度下降。
  • 注意力/处理速度及执行功能缺陷可能被误认为记忆问题,评估时需注意鉴别。

局限性

  • 横断面设计无法推断因果关系。
  • 样本中抗胆碱能负荷总体较低,可能限制对记忆关联的检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anticholinergic (AC) and sedative medications are a risk factor for cognitive impairment. This study sought to characterize AC and sedative use in older patients seen for outpatient neuropsychological evaluation and evaluate their associations with different cognitive domains. We hypothesized that AC and sedative use would be associated with worse attention/processing speed (AP), executive functioning (EF), and memory. METHODS: We conducted a cross-sectional chart review of 392 patients (mean [M] age = 72 ± 7.7 years, range = 54-91). Medications were characterized by number of AC medications (≥1 on the Anticholinergic Cognitive Burden Scale [ACB]), number of sedative medications, and polypharmacy (≥5 daily medications). Demographically adjusted composites were calculated for AP, EF, and memory. Bivariate Pearson correlations assessed relationships between medication use and cognition. Multivariate linear regressions evaluated significant medication-cognition associations, controlling for total medications, medical comorbidities, and estimated premorbid cognitive functioning. RESULTS: Polypharmacy was common (80%; n = 314). Most patients (70%; n = 275) used ≥1 sedative medications (range = 0-9). Over half (63%; n = 248) used ≥1 AC drugs (range = 0-7), yet ACB scores were ≤2 in 74% of patients. Sedative use was negatively correlated with AP (r = -0.134, p = 0.008) and EF (r = -0.105, p = 0.04). ACB scores were negatively correlated with AP (r = -0.106, p = 0.037). Sedatives and a priori covariates significantly predicted AP performance (R2 = 0.127, p < 0.001); using more sedative medications was uniquely associated with worse AP (β = -0.426, p = 0.049). No significant associations were found with memory. CONCLUSION: AC and sedative medications and polypharmacy were prevalent in this sample of older patients. Though both drug classes had negative relationships with AP and EF, sedatives had a particularly negative association with AP. Contrary to our hypotheses, memory was not associated with medication use; however, anticholinergic burden was low within the sample, and AP and EF deficits may masquerade as memory problems.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Hinkle CE, Davis JD, Arias I, et al. Anticholinergic and sedative medication use in older patients with cognitive concerns. J Am Geriatr Soc. 2024. PMID: 38685717. doi:10.1111/jgs.18933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。